Skip to main content

Table 2 Secondary outcomes

From: l-carnitine in critically ill patients—a case series study

  Carnitine elevation group (n = 14) Carnitine reduction group (n = 15) p value
f-Carnitine change from day 0 to day 14 (Δf-Carnitine) 12.2 (4.7~26.9) − 22.3 (− 34.8~− 4.4) < 0.01
Age 64.2 ± 17.0 61.8 ± 11.5 0.66
Body mass index 22.4 ± 2.8 19.4 ± 2.9 0.01
ICU duration 7.5 (3.0~13.7) 12.0 (5.0~21.0) 0.14
Sepsis during ICU stay 6 (40.0) 6 (42.8) 0.87
APACHE II score on admission 26.6 ± 8.7 29.4 ± 8.8 0.40
SOFA§ score on admission 8.0 ± 3.6 9.0 ± 4.6 0.53
Mechanical ventilation during ICU stay 0.0 (0.0~2.0) 4.0 (0.0~8.0) 0.08
Artificial nutrition at day 14 7 (42.8) 8 (53.3) 1.0
Parenteral nutrition at day 14 3 (21.4) 0 (0) 0.1
Enteral nutrition at day 14 4 (28.5) 8 (53.3) 0.26
Calorie intake per weight at day 14 26.4 ± 9.2 28.8 ± 8.4 0.46
Renal replacement therapy during ICU stay 6 (42.8) 9 (60.0) 0.46
  1. Data are presented as mean ± standard deviation, median (quartile), or absolute numbers and percentages (%) as appropriate
  2. Free carnitine
  3. Acute Physiology and Chronic Health Evaluation II
  4. §Sequential Organ Failure Assessment